Bausch Health Companies Inc. (BHC) Share Price Today, Stock Analysis, Annual Report | Value Research Bausch Health Companies Inc. (BHC) - Get live share price today, stock analysis, price valuation, performance, fundamentals, market cap, share holding, financial report of US stocks.

Bausch Health Companies Inc. (BHC)

Download Stock Report

NYSE: BHC

  • Price Change
  • Market Capitalisation market-capitalisation-info $3,019 Mln

  • 12 Month Earnings monthly-earning $-357 Mln
  • Price to Earnings price-to-earning --

Bausch Health Companies Inc. (BHC) Share Price

$8.22

As on 22-Sep-2023 16:10 EDT

up-down-arrow $-0.17-2.03%

  • Prev Close info

    $8.39

  • Day's Openinfo

    $8.45

  • Today's Highinfo

    $8.45

  • Today's Lowinfo

    $8.13

  • Today's Volumeinfo

    4,333,788

Please wait...

Bausch Health Companies Inc. (BHC) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Bausch Health Companies (BHC)
30.89 -2.72 11.53 15.77 -20.76 -19.89 -22.44
S&P BSE Healthcare*
20.70 -0.35 11.63 21.21 13.61 12.88 11.60
S&P Small-Cap 600#
-0.96 -4.96 -1.70 6.06 11.51 1.45 6.57
As on 22-Sep-2023  |  *As on 25-Sep-2023  |  #As on 25-Sep-2023
2022
2021
2020
2019
2018
2017
2016
Bausch Health Companies (BHC)
-77.25 32.74 -30.48 61.99 -11.06 43.11 -85.72
S&P Small-Cap 600
-17.42 25.27 9.57 20.86 -9.70 11.73 24.74
S&P BSE Healthcare
-12.10 20.87 61.45 -3.55 -5.89 0.49 -12.88

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Bausch Health Companies Inc. (BHC) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Bausch Health Companies Inc. (BHC)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        CEO & Director

        Mr. Thomas J. Appio

        Exec. VP & CFO

        Mr. Thomas G. Vadaketh

        Headquarters

        Laval, QC

        FAQs for Bausch Health Companies Inc. (BHC)

        The total asset value of Bausch Health Companies Inc. (BHC) stood at $ 29,368 Mln as on 31-Mar-23

        The share price of Bausch Health Companies Inc. (BHC) is $8.220000 (NYSE) as of 22-Sep-2023 16:10 EDT. Bausch Health Companies Inc. (BHC) has given a return of -20.76% in the last 3 years.

        Bausch Health Companies Inc. (BHC) has a market capitalisation of $ 3,019 Mln as on 19-May-2023. As per Value Research classification, it is a Small Cap company.

        The P/B ratio of Bausch Health Companies Inc. (BHC) is 18.78 times as on 19-May-2023, a 5.66% premium to its peers’ median range of 2.82 times.

        Since, TTM earnings of Bausch Health Companies Inc. (BHC) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Bausch Health Companies Inc. (BHC) and enter the required number of quantities and click on buy to purchase the shares of Bausch Health Companies Inc. (BHC).

        Bausch Health Companies Inc. operates as a diversified pharmaceutical company. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

        The CEO & director of Mr. Thomas J. Appio. is Bausch Health Companies Inc. (BHC), and CFO & Sr. VP is Mr. Thomas G. Vadaketh.

        The promoters of Bausch Health Companies Inc. (BHC) have pledged 0% of the total equity as on Dec-22.

        Bausch Health Companies Inc. (BHC) Ratios
        Return on equity(%)
        --
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        -25.26
        Dividend yield(%)
        0

        No, TTM profit after tax of Bausch Health Companies Inc. (BHC) was $-357 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $3,018.91 Mln
        • Revenue (TTM)revenue-information $8,150.00 Mln
        • Earnings (TTM) earning-information $-357.00 Mln
        • Cash date-information $518.00 Mln
        • Total Debt info $20,653.00 Mln
        • Insider's Holding 7.79%
        • Liquidity liquidity High
        • 52 Week range week-range $5.57 - 10.23
        • Shares outstanding share-outstanding 363,724,000
        • 10 Years Aggregate:

          CFO: $14,725.06 Mln

          EBITDA: $24,458.20 Mln

          Net Profit: $-7,888.34 Mln

        About The Company

        • IPO Date 29-Mar-1994
        • CEO & Director Mr. Thomas J. Appio
        • Exec. VP & CFO Mr. Thomas G. Vadaketh
        • Listing key-listing NYSE: BHC
        • Country Canada
        • Headquarters headquarters Laval, QC
        • Website website https://www.bauschhealth.com
        • Business

          Bausch Health Companies Inc. operates as a diversified pharmaceutical company. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye...  health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        share-fund-plan-icon